TCM
ELV icon

Tekla Capital Management’s Elevance Health ELV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$50.7M Hold
114,070
1.98% 16
2023
Q1
$52.5M Buy
114,070
+99,426
+679% +$45.7M 2% 16
2022
Q4
$7.51M Hold
14,644
0.28% 67
2022
Q3
$6.65M Hold
14,644
0.27% 69
2022
Q2
$7.07M Hold
14,644
0.28% 71
2022
Q1
$7.19M Hold
14,644
0.25% 76
2021
Q4
$6.79M Hold
14,644
0.22% 87
2021
Q3
$5.46M Sell
14,644
-93,090
-86% -$34.7M 0.18% 103
2021
Q2
$41.1M Sell
107,734
-57,043
-35% -$21.8M 1.34% 20
2021
Q1
$59.1M Buy
164,777
+127,644
+344% +$45.8M 2.03% 13
2020
Q4
$11.9M Hold
37,133
0.42% 70
2020
Q3
$9.97M Sell
37,133
-3,109
-8% -$835K 0.37% 62
2020
Q2
$10.6M Sell
40,242
-25,326
-39% -$6.66M 0.4% 52
2020
Q1
$14.9M Sell
65,568
-36,464
-36% -$8.28M 0.67% 34
2019
Q4
$30.8M Sell
102,032
-19,100
-16% -$5.77M 1.17% 20
2019
Q3
$29.1M Buy
121,132
+17,676
+17% +$4.24M 1.27% 20
2019
Q2
$29.2M Sell
103,456
-37,902
-27% -$10.7M 1.19% 20
2019
Q1
$40.6M Buy
141,358
+211
+0.1% +$60.6K 1.65% 15
2018
Q4
$37.1M Hold
141,147
1.59% 18
2018
Q3
$38.7M Buy
141,147
+30,514
+28% +$8.36M 1.4% 18
2018
Q2
$26.3M Buy
110,633
+19,151
+21% +$4.56M 1% 28
2018
Q1
$20.1M Buy
91,482
+46,564
+104% +$10.2M 0.78% 31
2017
Q4
$10.1M Hold
44,918
0.39% 54
2017
Q3
$8.53M Buy
+44,918
New +$8.53M 0.3% 63